Biotech Showcase 2027
Biotech Showcase brings together biopharma executives, investors and innovators in San Francisco.
- Date
- January 11, 2027
- Location
- San Francisco, CA
- Audience
- 3,200+ global biopharma leaders, including 1,200+ investors
TL;DR
- The 2027 event starts January 11 in San Francisco, California.
- The organizer describes a gathering of more than 3,200 global biopharma leaders, among them over 1,200 investors.
- The event lists more than 6,000 one-to-one meetings through partneringONE.
Who you'll find in the room
Biopharma leaders
Biopharma leaders are among the stated audience.
Investors
Investors are included in the stated audience.
Innovators
Innovators are included in the stated audience.
Industry leaders
Industry leaders are included in the stated audience.
Featured speakers
117 listedJulie Adrian
Co-Founder & CEO Alverium Health
Virginia Amann
Founder ENTENTE Network
Jim Anthony
Chief Commercial Officer & President Parexel Biotech
Annalee Armstrong
Senior Editor BioSpace
Somer Baburek
President, CEO & Board Member HERAbiotech
Thomas Barker
Partner, Co-Chair, Healthcare Department Foley Hoag
Vasundhara Bhargava
Deal Professional Principal Patient Square Capital
Gwendolyn Binder
President, Science and Technology Cabaletta Bio
Fritz Bittenbender
Board Chair, BIO & SVP Genentech
Eric Blouin
SVP, Oncology Ipsos Healthcare Advisory
Martin Brenner
CEO & CSO iBio
Steve Brozak
Managing Partner & President WBB Securities LLC
Grant Castor
SVP, Commercial Strategy & Operations Sentynl
Grace E. Colón
Board Chair, Aronora Biosciences, Bloom Science and Emm, Board Member BIO and MIT
Jonah Comstock
Editor in Chief pharmaphorum
Trish Costello
Founder & CEO Portfolia
Tamara Darsow
SVP, Global Business Development Novo Nordisk
Allison DeAngelis
Reporter STAT
Marc Dechamps
CEO Bioxodes
Lori Ellis
Market Intelligence Advisor Consultant
David Ewing Duncan
Journalist, Author Researcher
Jessica Federer
Board Member Angelini Ventures
Ryan Field
CEO Kernel
Eva Fortea-Verdejo
VP, Equity Research, Biotechnology Wells Fargo Corporate & Investment Banking
Alice Gilman
Co-Founder & COO R3 Biotechnologies
Jen Goldsack
CEO Digital Medicine Society (DiMe)
Jessica Green
Program Manager, Resilient Systems ARPA-H
Ignacio Guerrero-Ros
VP Russo Partners
Kimberly Ha
Founder & CEO KKH Advisors
Jay Hartenbach
President & COO Diakonos Oncology
Theresa Heah
CEO Eyexora
James Healy
Managing Partner Sofinnova Investments
Curt Herberts
Former President & COO Kriya Therapeutics
Echo Hindle-Yang
Founder & CEO MSQ Ventures
Lynelle Hoch
President, Cell Therapy Organization Bristol Myers Squibb
Tim Hunt
CEO Alliance for Regenerative Medicine
Nouhad Husseini
SVP, Head, BD & Corporate Strategy Regeneron Pharmaceuticals
Anthony Jarkowski, III
SVP, Primary Focus Lead, Head, Immuno-oncology Astellas
David Jenkins
SVP, Head, External Innovation and Research Ipsen
Alex Kadet
CBO Gero
Sanjay Kakkar
CEO Tensive
Konstantina Katcheves
SVP & Chief Business and Strategy Officer Acadia Pharmaceuticals
Natalie Kates
Acting Director, Scalable Solutions ARPA-H
Amanda Kay
Senior Partner & Chief Business Development Officer Flagship Pioneering
Hans Keirstead
Chairman Immunis, Inc.
Oliver Keown
CEO & Founder Oath Surgical
Themasap Khan
Co-Founder & Partner Luma Group
Navjeewan Khosla
Partner Novo Holdings Asia
Minji Kim
Entrepreneur in Residence Formation Bio
Mark Kotter
Executive Chairman, Scientific Founder clock.bio
Daniella Kranjac
Founding General Partner Avant Bio
Ken-ichiro Kuninobu
Co-founder & CEO FELIQS
Kyle LaHucik
Senior Reporter Endpoints News
Andrew Lam
Managing Director, Head, Biotech Private Equity Ally Bridge Group
Michael Langer
Co-Founder & Managing Partner T.Rx Capital
Kelly Laurel
CEO SurgiBox
Ron Leuty
Senior Reporter San Francisco Business Times
Jeremy Levin
Chairman & CEO Ovid Therapeutics Inc.
Raven Lin
CEO Pilatus Biosciences
Sean Lin
CEO ChemLex
Philippe Lopes-Fernandes
Executive VP & CBO Ipsen
Mr. Timothy Lu
Co-founder & CEO Senti Bio
Natalie Ma
Head, BD Deep Origin
Alastair MacDonald
Global Head, Medical Affairs & Growth Strategy Sciensus
Marinna Madrid
Co-Founder & Chief Product Officer Cellino
Katya Magonova
Managing Director, Commercial Advisory Syneos Health
George Magrath
CEO Opus Genetics
Maite Malet
Principal Asabys Partners
Michael Margolis
Senior Managing Director, Head, Healthcare Investment Banking Oppenheimer & Co. Inc.
Michael McCullar
CEO RegCell
Wyatt McDonnell
CEO Infinimmune
Jane Metcalfe
Executive Chair Human Immunome Project
Michael Meyers
Vice Chairman, Head, M&A and Strategic Advisory Services H.C. Wainwright & Co. LLC
Vivek Mittal
Partner, Managing Director & Head, Biopharma Health Advances
Aaron Morris
Co-Founder & CEO PostEra
Ravit Netzer
Co-Founder & CEO Scala Biodesign
Wonhee Oh
VP, Healthcare Investment Banking J.P. Morgan
Tim Opler
Managing Director, Global Healthcare Group Stifel
Jack O’Meara
CEO Aerska
Art Pappas
Managing Partner Pappas Capital
Mr. Neel Patel
Head, NewCo Business Development Flagship Pioneering
Ritish Patnaik
CEO Curve Biosciences
Adam Pearson
Chief Strategy Officer Astellas
Alex Philippidis
Senior Business Editor GEN
Maria Luisa Pineda
CEO & Co-Founder Envisagenics
Linda Pullan
Founder Pullan Consulting
Cameron Pye
Co-Founder & CEO Unnatural Products Inc.
Maha Radhakrishnan
Executive Partner Sofinnova Investments
Priyanka Rao
Venture Fellow H/L Ventures
Rachel Ravens
CEO & Partner 42Genetics, 46Health
Lori Reilly
COO PhRMA
Niels Riedemann
CEO InflaRx
MaryAnne Rizk
Managing Director, Head, Healthcare & Life Science Clinical Strategy Amazon Web Services (AWS)
Kate Rochlin
COO IN8bio
Beth Rogozinski
CEO Oncoustics
Peter Rubin
Executive Director No Patient Left Behind
Jarod Rutledge
Director, Biotech Investments Starbloom Capital
Helen Sabzevari
President & CEO Precigen
Amber Salzman
CEO Epicrispr Biotechnologies
Adam Schayowitz
Chief Development Officer Zymeworks
David Schull
President Russo Partners
Denise Scots-Knight
CEO Mereo BioPharma
Stacey Seltzer
Managing Partner & Founder Pontiva Healthcare Partners
Paul Sheehan
Program Manager, Resilient Systems ARPA-H
Joe Shonkwiler
Head, Healthcare & Life Science, Venture Capital BD Google
Kristina Simmons
Founder & Managing Partner Overwater Ventures
Curran Simpson
President and CEO REGENXBIO
Greg Skalicky
President EVERSANA
Bob Smith
Venture Partner, OrbiMed
Chairman Alliance for Regenerative Medicine
Tari Suprapto
Senior Director & Head, Global Innovation Sourcing Novo Nordisk
Ashish Tripathi
CEO Tzar Labs
Andy Udell
CCO Actinogen Medical
Brent Vaughan
CEO & Co-Founder Eratos Therapeutics, Inc.
Tracy Warren
Senior Managing Director Go Red for Women Fund, AHA Ventures, American Heart Association
Daniel Wee
Chief eXecution Officer Enveda
Emma Wheatley
Executive Director Access
Questions people ask
6 answeredThe event starts January 11, 2027.
Biotech Showcase 2027 is held in San Francisco, California.
The organizer cites more than 3,200 global biopharma leaders, including over 1,200 investors.
The stated audience includes biopharma leaders, investors, innovators and industry leaders.
Dealmakers get the most from it: founders and executives courting capital, business development staff hunting for partners, and investors sourcing deals, since the organizer reports about 3,200 attendees, among them 1,200 or more investors, plus a scheduled meeting system run through partneringONE. The speakers include a Genentech SVP who chairs the BIO board, a deal professional from Patient Square Capital and reporters from STAT and BioSpace, which points to a finance and business audience, so bench scientists wanting deep technical sessions will get less from it.
Attendees at biopharma investor conferences in San Francisco usually wear business casual to smart business attire, often a blazer with no tie, since days are spent in back-to-back meetings. Layers suit San Francisco in January, along with comfortable shoes for moving between meetings.
Related events
Find more events with this kind of reach.
We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.
Also listed in